排序方式: 共有2条查询结果,搜索用时 187 毫秒
1
1.
2.
Matthew M. Edey Pumali N. Gunasekera Mark Lobb Muhammad Imran 《Transplant infectious disease》2021,23(1):e13454
Pneumocystis jirovecii is an opportunistic pathogen that may cause severe, life‐threatening respiratory infections in immunocompromised patients such as those with kidney transplants. Although antimicrobial prophylaxis is now universally recommended in the early post‐transplant period, Pneumocystis pneumonia (PCP) can occur later. If such infection occurs, mortality rates are high. Beyond standard therapy with trimethoprim‐sulfamethoxazole, there is a lack of evidence‐based options for intensifying treatment when initial therapy fails to show improvement. Moreover, it is usual to minimize immunosuppression in life‐threatening infection, but graft damage may occur, particularly in kidney transplant recipients at above‐average immunological risk. Here we present two cases of severe PCP in high immunological risk recipients who were managed with adjunctive intravenous immunoglobulin and withdrawal of immunosuppression. Both patients recovered and were discharged from hospital with functioning grafts. 相似文献
1